Dyscovry Science

According to information procured exclusively by Benzinga ahead of an official announcement, global psychedelics company Silo Wellness Inc. (OTCQB: SILFF) (CSE: SILO) (FSE: 3K7A) is acquiring Dyscovry Science Ltd., a Toronto-based biotech company focused on biosynthetic manufacturing of...

Silo Wellness Inc. (CSE: SILO) (OTCQB: SILFF) (FRA: 3K70), a leading global psychedelics company, announced on Thursday that its founder and chairman of the board of directors Mike Arnold is assuming the role of interim CEO. Arnold will “continue to lead the Company through its planned...